Document Detail


Effect of myxothiazol on Leydig cell steroidogenesis: inhibition of luteinizing hormone-mediated testosterone synthesis but stimulation of basal steroidogenesis.
MedLine Citation:
PMID:  17332065     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Studies of MA-10 Leydig cells have shown that intact mitochondria with active respiration are essential for LH-induced Leydig cell steroidogenesis. To further elucidate the role played by mitochondria in steroidogenesis, we examined the effects of the perturbation of the mitochondrial electron transport chain with myxothiazol (MYX) on testosterone production by primary cultures of Brown Norway rat Leydig cells. Analysis of the steroidogenic pathway revealed that cAMP production and the activities of each of 3beta-hydroxysteroid dehydrogenase, 17alpha-hydroxylase/C17-20 lyase, and 17beta-hydroxysteroid dehydrogenase were inhibited by MYX and that LH-stimulated testosterone production was suppressed. In contrast to the inhibition of LH-stimulated testosterone production by MYX, the incubation of Leydig cells with MYX in the absence of LH stimulated testosterone production. Although testosterone production was increased, steroidogenic acute regulatory protein was decreased in response to MYX, not increased as could be expected. Additional electron transport chain inhibitors had stimulatory effects on testosterone production that were similar to those of MYX, strongly suggesting that the effect of MYX on basal testosterone production is related to its effect on the mitochondrial electron transport chain. Finally, incubation of the cells with a combination of MYX and the calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetracetic acid tetrakis acetoxymethyl ester suppressed MYX-mediated increased basal steroidogenesis but had no effect on hydroxycholesterol-mediated steroidogenesis. Taken together, these results indicate that inhibition of the mitochondrial electron transport chain can block LH-stimulated testosterone production through suppression of a number of steps of the steroidogenic pathway but also stimulates basal testosterone production through a calcium-mediated mechanism.
Authors:
Andrew S Midzak; June Liu; Barry R Zirkin; Haolin Chen
Related Documents :
17992635 - Diverse fsh and testosterone signaling pathways in the sertoli cell.
7702875 - Role of sulfated glycoprotein-1 (sgp-1) in the disposal of residual bodies by sertoli c...
736275 - Effects of testosterone enanthate on the structure of the male reproductive tract of th...
12056625 - Immunohistochemical localization of androgen receptors in testicular cells of mice with...
9434135 - Increased cellular triglyceride levels in human monocytic and rat smooth muscle cells a...
15930335 - Critical role of peroxisome proliferator-activated receptor gamma on anoikis and invasi...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2007-03-01
Journal Detail:
Title:  Endocrinology     Volume:  148     ISSN:  0013-7227     ISO Abbreviation:  Endocrinology     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-05-17     Completed Date:  2007-07-24     Revised Date:  2007-12-03    
Medline Journal Info:
Nlm Unique ID:  0375040     Medline TA:  Endocrinology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2583-90     Citation Subset:  AIM; IM    
Affiliation:
Department of Biochemistry and Molecular Biology, Division of Reproductive Biology, Johns Hopkins University Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Leydig Cells / drug effects*,  metabolism*
Luteinizing Hormone / pharmacology*
Male
Methacrylates / pharmacology
Mitochondria / drug effects,  physiology
Rats
Rats, Inbred Strains
Signal Transduction
Steroids / biosynthesis*
Testosterone / biosynthesis*
Thiazoles / pharmacology
Grant Support
ID/Acronym/Agency:
AG 026721/AG/NIA NIH HHS; AG 21092/AG/NIA NIH HHS; ES 07141/ES/NIEHS NIH HHS
Chemical
Reg. No./Substance:
0/Methacrylates; 0/Steroids; 0/Thiazoles; 58-22-0/Testosterone; 76706-55-3/myxothiazol; 9002-67-9/Luteinizing Hormone
Comments/Corrections
Comment In:
Endocrinology. 2007 Jun;148(6):2581-2   [PMID:  17507576 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone.
Next Document:  Altered expression of genes involved in regulation of vitamin A metabolism, solute transportation, a...